Association of baseline anti-Ro52 seropositivity with connective tissue disease development following interferon-α therapy in patients with chronic hepatitis B.
- DOI
- 10.1007/s10067-026-08317-2
- Published
- 2026 Oct
- Container
- Clinical rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10067-026-08317-2,
title = {Association of baseline anti-Ro52 seropositivity with connective tissue disease development following interferon-α therapy in patients with chronic hepatitis B.},
author = {Ma Y and Qian H and Zheng C and Deng C and Liu X and Xue X and Li Z and Shi G and Sun Y},
year = {2026},
journal = {Clinical rheumatology},
doi = {10.1007/s10067-026-08317-2},
url = {https://doi.org/10.1007/s10067-026-08317-2}
}RIS
TY - JOUR TI - Association of baseline anti-Ro52 seropositivity with connective tissue disease development following interferon-α therapy in patients with chronic hepatitis B. AU - Ma Y AU - Qian H AU - Zheng C AU - Deng C AU - Liu X AU - Xue X AU - Li Z AU - Shi G AU - Sun Y PY - 2026 JO - Clinical rheumatology DO - 10.1007/s10067-026-08317-2 UR - https://doi.org/10.1007/s10067-026-08317-2 ER -
APA
Y, M., H, Q., C, Z., C, D., X, L., X, X., Z, L., G, S., & Y, S. (2026). Association of baseline anti-Ro52 seropositivity with connective tissue disease development following interferon-α therapy in patients with chronic hepatitis B.. Clinical rheumatology. https://doi.org/10.1007/s10067-026-08317-2
Source records
- pubmed · retrieved 2026-09-26T18:18:28.976Z